Cutler Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
WP
PAMS
Cutler Group's EDIT Position: Q1 2023 in Review
Cutler Group sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 100 shares.
Cutler Group first reported a position in EDIT in Q1 2017 and held it in 24 quarters. The position peaked at $409K in Q4 2021. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.
- Cutler Group reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
- Cutler Group sold 100 Editas Medicine shares in Q1 2023.
- Cutler Group first reported a position in Editas Medicine in Q1 2017 and held it in 24 quarters.
- Cutler Group's Editas Medicine position peaked at $409K in Q4 2021.
- 234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.
Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.